Anteilseigner
Snehal S. Patel (41,55 %) David B. McWilliams,
MBA (4,82 %) Kenneth Hallock,
MBA (3,09 %) Jaye L. Thompson,
PhD (2,02 %) The Vanguard Group, Inc. (1,72 %) F. Joseph Daugherty,
III,
MD (0,70 %) Degroof Petercam Asset Services SA (0,68 %) Millennium Management LLC (0,50 %) Geode Capital Management LLC (0,45 %) BlackRock Fund Advisors (0,43 %) Goldman Sachs & Co. LLC (Private Banking) (0,32 %) Renaissance Technologies LLC (0,29 %) Susquehanna Financial Group LLLP (0,28 %) Qube Research & Technologies Ltd. (0,13 %) Northern Trust Investments, Inc.(Investment Management) (0,12 %) HRT Financial LLC (0,12 %) SSgA Funds Management, Inc. (0,10 %) AHL Partners LLP (0,09 %) Citigroup Global Markets, Inc. (Investment Management) (0,06 %)
Kontakt
Greenwich Lifesciences Inc.